Citicoline (CDP-choline, cytidine 5'-diphosphocholine) is a naturally occurring endogenous compound and a highly bioavailable choline supplement with a uniquely dual mechanism: it supplies both choline (for acetylcholine synthesis) and cytidine (which converts to uridine in the body, a building block for neuronal membrane phospholipids). This dual action makes citicoline pharmacologically distinct from simpler choline sources such as choline bitartrate, and gives it a broader neuroprotective profile.
In the body, citicoline is produced as an intermediate in the Kennedy pathway — the metabolic route by which phosphatidylcholine is synthesized in cell membranes. Supplemental citicoline is cleaved in the gut to choline and cytidine, then resynthesized back to CDP-choline in the brain, providing both the cholinergic and phospholipid membrane-building benefits simultaneously. This neuroprotective profile has made citicoline the subject of clinical research in stroke, traumatic brain injury, glaucoma, and cognitive aging.
In terms of choline bioavailability to the brain, citicoline appears to be comparable to Alpha-GPC and superior to choline bitartrate. However, its primary distinction lies in the additional effects of uridine: increased synthesis of phosphatidylcholine membranes, potentiation of dopaminergic neurotransmission, and synergistic effects with other omega-3 fatty acids and B vitamins in supporting neuronal function. Community experience emphasizes that citicoline tends to produce a cleaner, less "heavy" feeling than high-dose choline bitartrate, with a slightly more mood-elevating quality that some users attribute to the cytidine/uridine component.